Status:
COMPLETED
Costs and Effects of Three Modes for Disease Management of Chronic Obstructive Pulmonary Disease in General Practice
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
ZonMw: The Netherlands Organisation for Health Research and Development
PICASSO: Partners in Care Solutions for COPD
Conditions:
Lung Diseases, Obstructive
Eligibility:
All Genders
35+ years
Phase:
NA
Brief Summary
In this randomized controlled trial, three contemporary modes for chronic obstructive pulmonary disease (COPD) management in Dutch general practices are compared for costs and effects: * usual genera...
Detailed Description
Considering the ageing of the Dutch population and the current and increasing shortage of general practitioners (GPs), the capacity of primary healthcare is a major and growing concern. Delegation of ...
Eligibility Criteria
Inclusion
- Registered in one of the general practices participating in the study
- Diagnosis of COPD, with Global Initiative for Chronic Obstructive Lung Diseases (GOLD) stage I, II or III
- Age ≥35 years
- Willing to provide written informed consent
Exclusion
- Very poor prognosis with regard to respiratory condition (GOLD stage IV)
- Severe co-morbid conditions with a reduced life expectancy
- Unable to communicate in the Dutch language
- Objections to one or more of the disease management modes in the study
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2008
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT00128765
Start Date
January 1 2005
End Date
December 1 2008
Last Update
November 22 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University, Department of General Medicine
Nijmegen, Netherlands, 6500 HB